Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section listing Guangdong as a study site and updated revision to v3.3.3; Guangdong Locations was removed as part of the update.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.1%

- Check32 days agoChange DetectedPublications section now clarifies that listed publications are automatically filled from PubMed, and a revision note shows Revision: v3.3.1, replacing the previous wording (Revision: v3.2.0).SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding status notice was removed from the page. It previously warned that updates may not be up to date and directed users to opm.gov for updates.SummaryDifference0.4%

- Check54 days agoChange DetectedNew metadata entries were added indicating the last known status, the investigator Yanhong Deng from Sun Yat-sen University, the date by 2023-10, and verification status.SummaryDifference0.8%

- Check82 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference4%

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.